Contravir Pharmaceuticals (CTRV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CTRV | AMGN | VRTX | BMY | REGN |
| Company | Contravir Pharmaceuticals | Amgen Inc | Vertex Pharmaceutic | Bristol-Myers Squibb Company | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NYSE | NASDAQ |
| Open | 3.59 | 313.39 | 401.50 | 43.90 | 926.94 |
| High | 3.70 | 322.60 | 405.67 | 44.33 | 955.69 |
| Low | 3.53 | 308.68 | 397.59 | 43.69 | 926.94 |
| Last | 3.58 | 310.82 | 401.42 | 43.96 | 955.77 |
| Change | +0.02 | +32.43 | +1.26 | +0.26 | +18.16 |
| % Change | +0.56% | +11.65% | +0.31% | +0.59% | +1.94% |
| Volume | 139,100 | 8,203,848 | 659,930 | 8,147,550 | 311,123 |
| 20-Day Average Volume | 475,720 | 2,552,939 | 999,303 | 14,244,226 | 505,162 |
| Previous Close | 3.56 | 278.39 | 400.16 | 43.70 | 937.61 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 3.95 | 272.15 | 398.49 | 47.45 | 909.77 |
| 20-Day Raw Stochastic | 3.57% | 77.96% | 71.20% | 5.95% | 99.81% |
| 20-Day Relative Strength | 38.85% | 71.29% | 48.20% | 28.27% | 58.64% |
| Weighted Alpha | -86.50 | +32.44 | +14.86 | -36.99 | +26.34 |
| Today's Opinion | 100% Sell | 24% Buy | 8% Buy | 100% Sell | 72% Buy |
| Previous Opinion | 100% Sell | 16% Sell | 8% Buy | 88% Sell | 48% Buy |
| Last Month's Opinion | 100% Sell | 24% Sell | 24% Buy | 8% Sell | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -7.01% since 07/15/19 | +14.43% since 04/26/24 | +1.23% since 04/26/24 | -2.27% since 04/26/24 | +8.13% since 04/26/24 |
| Low | 3.53 on 07/22/19 | 268.99 on 04/29/24 | 391.70 on 04/30/24 | 43.33 on 05/02/24 | 883.20 on 04/29/24 |
| High | 3.98 on 07/17/19 | 322.60 on 05/03/24 | 406.95 on 05/01/24 | 45.38 on 04/29/24 | 955.20 on 05/03/24 |
| 1-Month | |||||
| %Chg | -31.15% since 06/21/19 | +12.58% since 04/03/24 | -1.58% since 04/03/24 | -16.00% since 04/03/24 | +0.43% since 04/03/24 |
| Low | 3.52 on 07/05/19 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 43.33 on 05/02/24 | 875.22 on 04/26/24 |
| High | 5.20 on 06/24/19 | 322.60 on 05/03/24 | 412.64 on 04/04/24 | 52.08 on 04/04/24 | 962.20 on 04/04/24 |
| 3-Month | |||||
| %Chg | -75.65% since 04/22/19 | -4.41% since 02/02/24 | -5.26% since 02/02/24 | -10.02% since 02/02/24 | +1.04% since 02/02/24 |
| Low | 3.52 on 07/05/19 | 260.68 on 04/19/24 | 391.01 on 04/18/24 | 43.33 on 05/02/24 | 875.22 on 04/26/24 |
| High | 16.49 on 06/17/19 | 329.72 on 02/05/24 | 437.00 on 02/27/24 | 55.03 on 03/13/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | -84.50% since 01/22/19 | +14.49% since 11/03/23 | +6.95% since 11/03/23 | -17.02% since 11/03/23 | +16.91% since 11/03/23 |
| Low | 3.52 on 07/05/19 | 260.52 on 11/21/23 | 341.90 on 11/16/23 | 43.33 on 05/02/24 | 783.57 on 11/10/23 |
| High | 25.20 on 03/01/19 | 329.72 on 02/05/24 | 448.40 on 01/30/24 | 55.03 on 03/13/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 2,874 | 149,321,728 | 103,424,960 | 88,584,272 | 102,913,952 |
| Shares Outstanding, K | 803 | 536,376 | 258,459 | 2,027,100 | 109,762 |
| Annual Sales | 0 | 28,190,000,000 | 9,869,200,000 | 45,006,000,000 | 13,117,200,000 |
| Annual Net Income | -9,450,000 | 6,717,000,000 | 3,619,600,000 | 8,025,000,000 | 3,953,600,000 |
| Last Quarter Sales | N/A | 8,196,000,000 | 2,517,700,000 | 11,865,000,000 | 3,434,300,000 |
| Last Quarter Net Income | N/A | 767,000,000 | 968,800,000 | -11,911,000,000 | 1,159,600,000 |
| 60-Month Beta | 1.17 | 0.60 | 0.39 | 0.45 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 3.96 on 05/02/24 | 4.20 on 02/05/24 | -4.40 on 04/25/24 | 9.55 on 05/02/24 |
| Latest Earnings Date | 05/23/18 | 05/02/24 | 05/06/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | N/A | 0.600 on 04/04/24 | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | N/A | 04/04/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.87 | 29.92 | 42.10 | 24.04 |